Abdul Mannan: Advances in the Management of Von Willebrand Disease
Abdul Mannan, Consultant Haematologist, Director Haemophilia Centre, Haematology Lab Lead Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn.
“Von Willebrand Disease just got a major upgrade.
I made this infographic video to show you exactly how.
17 practice-changing advances. All in one place.
Watch this if you manage VWD patients (or teach anyone who does):
What’s inside:
- Recombinant VWF with double the half-life (20 hours vs 10)
- Novel biologics that work completely differently (emicizumab, HMB-002)
- The 2-4-50 rule for desmopressin testing (simple, powerful)
- Prophylaxis data: 84-91% fewer bleeds
- Pregnancy protocols that actually work (VWF targets + postpartum timelines)
Patient outcomes that finally include reproductive health
Why this matters: We’ve shifted from reactive to proactive care. From guesswork to precision medicine.
The infographic breaks down complex mechanisms into simple visuals.
- Treatment algorithms.
- Before and after comparisons.
- Timeline graphics.
Everything you need to update your practice in under 5 minutes.
Hit play. These advances are too good to miss.
What’s the biggest VWD challenge in your clinic right now?”
View the Infographic Video Outlining These Advances.

More posts from Abdul Mannan on Hemostasis Today.
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA